总时间（秒）：22.09
问答时间（秒）：20.76

```json
[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper explores the role of EGFR mutations in cancer development and their impact on tyrosine kinase activity, cell proliferation, and downstream signaling pathways.",
        "judgment": "Yes",
        "reasoning": "The paper explicitly states that EGFR mutations drive oncogenesis and affect crucial cellular processes.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field.",
        "extracted_paper_info": "The assays described—enzymatic activity assays—directly assess the effect of the mutation on EGFR tyrosine kinase function, directly modeling the mechanism of EGFR-driven tumorigenesis.",
        "judgment": "Yes",
        "reasoning": "Measuring enzymatic activity is a direct assessment of the mechanism affected by the mutation.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3a: Basic Controls and Replicates.",
        "extracted_paper_info": "The study used wild-type EGFR as a control. Triplicate measurements were performed for each condition.",
        "judgment": "Yes",
        "reasoning": "Both wild-type control and multiple replicates were included in the experiment.",
        "next_step_or_outcome": "Proceed to Step 3c"
      },
      {
        "step_name": "Step 3c: Variant Controls",
        "extracted_paper_info": "The study did not mention comparing the EGFR L858R variant against other known pathogenic/benign variants.",
        "judgment": "No",
        "reasoning": "The study did not use other known pathogenic or benign EGFR variants as controls.",
        "next_step_or_outcome": "Proceed to Step 4b"
      },
      {
        "step_name": "Step 4b: No OddsPath Calculation",
        "extracted_paper_info": "The paper describes significant reduction in EGFR kinase activity compared to the wild-type, but doesn't provide statistical analysis or odds ratios.",
        "judgment": "Yes",
        "reasoning": "No OddsPath calculation was performed.",
        "next_step_or_outcome": "Final Step"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_supporting"
    },
    "overall_conclusion": "The significant reduction in EGFR kinase activity observed with the L858R mutation, coupled with basic controls and replicates, supports a pathogenic role but lacks quantitative statistical analysis, resulting in a PS3_supporting classification."
  }
]
```